ScholarIQanswers from OpenAlex

Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2

PaperCitations, authors & open-access status

Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2 is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2 have?

ScholarIQcitation count

Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2 has 158 citations in the OpenAlex counts ScholarIQ stores.

When was Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2 published?

ScholarIQyear

Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2 has 2019 year in the ScholarIQ index.

What is the open-access status of Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2?

ScholarIQoa status

Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2 has closed oa status in the ScholarIQ index.

What is the DOI of Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2?

ScholarIQdoi

The DOI for Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2 is on the source record.

What is the PMID of Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2?

ScholarIQpmid

The PMID for Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2 is on the source record.

What is the OpenAlex record for Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2?

ScholarIQopenalex

The OpenAlex for Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2 is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial